Da Cunha AP et al. found that the administration of anti-LAP resulted in a significant reduction of the number of CD4+LAP+ T cells that populate the spleen and mesenteric lymph nodes, with no effect over the CD4+Foxp3+ T cell population in experimental autoimmune encephalomyelitis model. This evidence concerns the gene TGFB1 and experimental autoimmune encephalomyelitis.